The Economic and Clinical Value of OCT in Breast Cancer With: Adrian Mendes
Adrian Mendes, CEO of Perimeter Medical Imaging, explains how OCT (Optical Coherence Tomography) technology can significantly reduce healthcare costs by lowering the number of re-excisions in breast cancer surgeries. Referencing a study from MD Anderson, Mendes highlights that each re-excision can cost ,000–,000, with mastectomies reaching up to 0,000. Beyond direct costs, repeat surgeries strain hospital operating room availability and create emotional and physical burdens for patients and providers. Mendes emphasizes that payers and insurers stand to benefit economically from adopting OCT, while patients gain from improved outcomes and reduced stress.
Episode Contents:
About the Guest
Adrian Mendes is CEO of Perimeter Medical Imaging, where he leads the development of OCT imaging solutions to improve surgical outcomes and reduce healthcare costs.
Key Takeaways
Re-excisions cost ,000–,000 each; mastectomies can reach 0,000. Repeat surgeries strain operating room capacity and delay care. OCT adoption benefits patients, providers, and insurers alike.
Transcript Summary
How can OCT reduce healthcare costs?
By lowering re-excision rates in breast cancer surgeries, saving patients and payers tens of thousands per case.
What are the broader impacts?
Repeat surgeries strain operating room availability, raising costs across the system.
Who benefits most?
Patients gain better outcomes, while insurers avoid paying for costly second procedures.
More Topics
- AI in Patient Care
- AI in the Healthcare Industry
- AI and Medical Innovation
- Healthcare Ethics and Policy
Keep Exploring
About the Series
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine.
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine.
Mika Newton is an expert in healthcare data management, with a focus on data completeness and universality. Mika is on the editorial board of AI in Precision Oncology and is no stranger to bringing transformative technologies to market and fostering innovation.